Steraline’s VFCM100 guarantees sterility throughout the aseptic filling process via a double-wall isolator.
Steriline’s VFCM100
Steriline’s VFCM100, a vial-filling and capping machine equipped with a double-wall isolator, is a solution designed to increase contract development and manufacturing organization production capacity for COVID-19 vaccines. The machine is capable of reaching a production capacity of 6000 pieces per hour and was specifically developed for injectable drugs. It is equipped with four peristaltic pumps to allow for infinite filling capacity and 100% check-weighing. The machine can handle glass vials from 2 mL to 100 mL, and can also handle plastic vials via a format change.
The double-wall isolator is included to guarantee sterility throughout the aseptic filling process, minimizing the risk of product contamination. Once vials are capped, they are moved via conveyor belt into a printer where every cap is marked with the relative batch details for tracking purposes.
Drug Solutions Podcast: A Closer Look at mRNA in Oncology and Vaccines
April 30th 2024In this episode fo the Drug Solutions Podcast, etherna’s vice-president of Technology and Innovation, Stefaan De Koker, discusses the merits and challenges of using mRNA as the foundation for therapeutics in oncology as well as for vaccines.
Pharmaceutical Tariffs Are Imminent: How Industry is Bracing for Impact
April 16th 2025On April 14, 2025, the Trump Administration launched a national security-driven investigation into pharmaceuticals, a move that will likely result in tariffs being placed on pharmaceutical drugs, ingredients, and other components that are imported from outside of the United States.